September 13, 2019

Women Taking Paracetamol (Acetaminophen) In Pregnancy Risk Children Having Behavior Problems

Women who take paracetamol (acetaminophen) while pregnant risk having children with behavior problems, a study suggests.
September 12, 2019

Multibillion-Dollar Opioid Drug Maker Purdue Pharma Files For Bankruptcy Protection

Multibillion-dollar opioid drug maker Purdue Pharma has filed for bankruptcy protection. The company is facing more than 2,600 lawsuits alleging it helped fuel the deadly opioid epidemic in the United States.
September 5, 2019

Hundreds Of Thousands Of People In England Addicted To Prescription Drugs

Hundreds of thousands of people in England are believed to be addicted to prescription drugs. A recent review looked at the use of strong painkillers, antidepressants and sleeping tablets, used by a quarter of adults in England every year.
September 3, 2019

Los Angeles Times Publishes Opinion Article Criticizing Pharma Industry

The Los Angeles Times recently published a critical opinion article with the headline: Legal judgements against big pharma aren’t enough – Consumers need to change their drug habits.
September 2, 2019

Aspirin Should Not Be Recommended For Healthy People Aged Over 70

A new trial has found that low-dose aspirin does not prolong disability-free survival of healthy people aged over 70, even in those at the highest risk of cardiovascular disease.
August 30, 2019

Breast Cancer: Menopausal Hormone Replacement Therapy Risks ‘Bigger Than Thought’

The increased risk of breast cancer from menopausal hormone replacement therapy lasts more than a decade after treatment stops, a major report suggests.
August 29, 2019

Johnson & Johnson Court Verdict Sends Opioid Makers A Billion-Dollar Warning

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.
August 28, 2019

U.S. Drug Firms Eye Booming New Painkiller Market In India

As India loosens its stringent narcotics laws, U.S. drug companies are rushing in to take advantage.